5333.5000 10.50 (0.20%)
NSE Mar 17, 2026 15:31 PM
Volume: 127.2K
 

5333.50
0.20%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors increased from 589 to 613 in Dec 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended